Ethical Challenges in Acute Evaluation of Suspected Psychogenic Stroke Mimics
Alexandra J. Sequeira, Michael G. Fara, and Ariane Lewis, The Journal of Clinical Ethics 29, no. 3 (Fall 2018): 185-90.
Tissue plasminogen activator (tPA) is administered to patients with suspected ischemic stroke to improve blood flow to the brain In rare cases, patients present with complaints of stroke symptoms that appear to be non-organic due to malingering, factitious disorder, or conversion disorder (psychogenic stroke mimics). Deciding whether or not to administer tPA to these patients can be challenging. The risk of hemorrhage after administration of tPA is low, but not zero. The ethical principles of beneficence and nonmaleficence need to be weighed carefully in these situations. We present two cases of patients with suspected psychogenic stroke mimics to illustrate the ethical challenges faced in identifying and managing psychogenic stroke mimics. Further research is needed to demonstrate effective treatment strategies for patients with acute stroke symptoms of psychogenic etiology.
Purchasers receive a full-text .pdf file of the article to view, download, and/or print.
Access to the online .pdf will send when the purchaser closes the .pdf.